Core Viewpoint - The company anticipates achieving a revenue of no less than RMB 3 billion by 2025, representing a growth of at least 16% compared to the same period in 2024, alongside adjusted net profits of no less than RMB 3.8 billion, reflecting a growth of at least 40% [1] Group 1: Financial Projections - Expected revenue for 2025 is at least RMB 3 billion, a growth of no less than 16% from 2024 [1] - Adjusted net profit is projected to be no less than RMB 3.8 billion, indicating a growth of at least 40% compared to 2024 [1] - Net profit is anticipated to be no less than RMB 3.4 billion, with a growth of at least 34% from 2024 [1] Group 2: Reasons for Performance Improvement - Accelerated external expansion is a key driver, highlighted by the acquisition of the second-ranked brand in China's beauty industry, Nairui'er, which enhances market share and boosts revenue and profit [1] - Strong internal growth is noted, with an increase in brand momentum and customer numbers driving organic revenue growth, alongside a higher proportion of high-margin medical business revenue [1] - The company emphasizes a dual strategy of "internal growth + external acquisition" and aims to deepen its "dual beauty + dual healthcare" business model [1]
美丽田园医疗健康(02373)发盈喜 预期2025年经调整净利润不少于3.8亿元 同比增长不少于40%